Transgene's total assets for Q4 2024 were €42.17M, a decrease of -16.90% from the previous quarter. GB:0OCQ total liabilities were €26.97M for the fiscal quarter, a -47.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.